
On April 10, 2025, Dubai Medical University  had the honor of hosting Dr. Nalan Utku, a distinguished Professor of  Immunology at Charité – Universitätsmedizin Berlin and internationally  recognized biotech entrepreneur and innovator.
Dr. Utku, a clinician-scientist with over  two decades of experience in translational medicine, drug development, and  regulatory affairs, has led groundbreaking work in oncology and autoimmune  disease therapeutics. With multiple board positions, global patents, and  published scientific contributions, she continues to be a key advisor to  biopharmaceutical companies and venture capitalists across Europe and the US.
The visit began with a warm welcome  extended by the Vice Chancellor, Prof. Sherief Khalifa, and the Deans, who  introduced Dr. Utku to the DMU community and highlighted the significance of  her visit to the University’s academic and research missions.
At DMU, she delivered two inspiring  sessions. The first session for the DMU Students’ Career Session entitled “Overcoming  Barriers – Becoming a Biotech Entrepreneur.” Students were deeply inspired  as Dr. Utku shared her personal journey from her days as a medical student in  Germany, through her research fellowship at Harvard Medical School, to becoming  a biotech entrepreneur and scientific leader. 
The second session for the DMU Faculty  Research Seminar entitled “The Magic of Innovation – Transforming Knowledge  into New Medicine.” Faculty members were highly motivated by her  transformation of cutting-edge research into impactful therapies, leading to  the development of over 30 patents in cancer and immune therapies. Her insights  into translational medicine and academic entrepreneurship sparked exciting  conversations about future research directions at DMU.
Following the sessions, Prof. Sherief  Khalifa, along with members of the research team, accompanied Dr. Utku on a  tour of DMU’s research facilities, showcasing the university’s ongoing  initiatives and future aspirations in medical innovation.

© DMU - Dubai, United Arab Emirates